164 related articles for article (PubMed ID: 12578905)
21. Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomas: results of a prospective randomized trial of the German Low-Grade Lymphoma Study Group.
Nickenig C; Dreyling M; Hoster E; Pfreundschuh M; Trumper L; Reiser M; Wandt H; Lengfelder E; Unterhalt M; Hiddemann W;
Cancer; 2006 Sep; 107(5):1014-22. PubMed ID: 16878325
[TBL] [Abstract][Full Text] [Related]
22. Small bowel perforation caused by Epstein-Barr virus-associated B cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma.
Takahashi T; Maruyama R; Mishima S; Inoue M; Kawakami K; Onishi C; Miyake T; Tanaka J; Nabika T; Ishikura H
J Clin Exp Hematop; 2010; 50(1):59-63. PubMed ID: 20505277
[TBL] [Abstract][Full Text] [Related]
23. Ongoing remission after intensive ALL-type chemotherapy in pediatric intestinal T-cell lymphoma.
Friedrich C; Schrum J; Chott A; Janka-Schaub G; Kabisch H
Pediatr Blood Cancer; 2010 Apr; 54(4):610-2. PubMed ID: 20049930
[TBL] [Abstract][Full Text] [Related]
24. Chemotherapy-related nail toxicity.
Antonioli E; Fani A; Sordi B; Puccini B; Bosi A
Int J Hematol; 2019 Nov; 110(5):519-520. PubMed ID: 31401768
[No Abstract] [Full Text] [Related]
25. Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study.
Chiappella A; Martelli M; Angelucci E; Brusamolino E; Evangelista A; Carella AM; Stelitano C; Rossi G; Balzarotti M; Merli F; Gaidano G; Pavone V; Rigacci L; Zaja F; D'Arco A; Cascavilla N; Russo E; Castellino A; Gotti M; Congiu AG; Cabras MG; Tucci A; Agostinelli C; Ciccone G; Pileri SA; Vitolo U
Lancet Oncol; 2017 Aug; 18(8):1076-1088. PubMed ID: 28668386
[TBL] [Abstract][Full Text] [Related]
26. [Patient with Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma with Small Intestinal Perforation Development during Chemotherapy].
Kawakita H; Aota Y; Osaka Y; Sutoh A; Watanabe T; Sugiyama Y; Kato F; Enomoto M; Ishizaki T; Katsumata K; Nagakawa Y
Gan To Kagaku Ryoho; 2022 Dec; 49(13):1473-1475. PubMed ID: 36733106
[TBL] [Abstract][Full Text] [Related]
27. Involvement of the appendix in a relapsed case of primary nasal NK/T-cell lymphoma.
Tsujimura H; Takagi T; Tamaru J; Sakai C
Leuk Lymphoma; 2000 May; 37(5-6):633-4. PubMed ID: 11042526
[TBL] [Abstract][Full Text] [Related]
28. A four-year spontaneous remission of angioimmunoblastic T-cell lymphoma.
Cornish N; Maybury B; Otton S
Br J Haematol; 2018 Jan; 180(2):176. PubMed ID: 29048103
[No Abstract] [Full Text] [Related]
29. Upfront VIP-reinforced-ABVD (VIP-rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS-LTP95.
Simon A; Peoch M; Casassus P; Deconinck E; Colombat P; Desablens B; Tournilhac O; Eghbali H; Foussard C; Jaubert J; Vilque JP; Rossi JF; Lucas V; Delwail V; Thyss A; Maloisel F; Milpied N; le Gouill S; Lamy T; Gressin R
Br J Haematol; 2010 Oct; 151(2):159-66. PubMed ID: 20738307
[TBL] [Abstract][Full Text] [Related]
30. [Nasal NK cell lymphoma with hemophagocytic syndrome developed tumor lysis syndrome after CHOP therapy].
Sawada M; Yamada T; Tsurumi H; Moriwaki H
Rinsho Ketsueki; 2002 Nov; 43(11):988-92. PubMed ID: 12508484
[TBL] [Abstract][Full Text] [Related]
31. Role of a doxorubicin-containing regimen in relapsed and resistant lymphomas: an 8-year follow-up study of EPOCH.
Gutierrez M; Chabner BA; Pearson D; Steinberg SM; Jaffe ES; Cheson BD; Fojo A; Wilson WH
J Clin Oncol; 2000 Nov; 18(21):3633-42. PubMed ID: 11054436
[TBL] [Abstract][Full Text] [Related]
32. A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): final results from the T- cell consortium trial.
Advani RH; Ansell SM; Lechowicz MJ; Beaven AW; Loberiza F; Carson KR; Evens AM; Foss F; Horwitz S; Pro B; Pinter-Brown LC; Smith SM; Shustov AR; Savage KJ; Vose JM
Br J Haematol; 2016 Feb; 172(4):535-44. PubMed ID: 26627450
[TBL] [Abstract][Full Text] [Related]
33. [Clinical randomized comparative trial of ProMACE-CytaBOM regimen and CHOP regimen in treating non-Hodgkin's lymphoma].
Hou M; Li L; Qiu M; Yan X; Zhu J; Gou HF
Ai Zheng; 2005 Apr; 24(4):461-4. PubMed ID: 15820070
[TBL] [Abstract][Full Text] [Related]
34. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.
Fisher RI; Gaynor ER; Dahlberg S; Oken MM; Grogan TM; Mize EM; Glick JH; Coltman CA; Miller TP
N Engl J Med; 1993 Apr; 328(14):1002-6. PubMed ID: 7680764
[TBL] [Abstract][Full Text] [Related]
35. [Doxorubicin and etoposide-besed combination chemotherapy regimen for peripheral T-cell lymphoma].
Zheng W; Zhu J; Xie Y
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):875-6. PubMed ID: 19173838
[No Abstract] [Full Text] [Related]
36. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
37. [T-cell rich B-cell lymphoma associated with hemophagocytic syndrome].
Dommann-Scherrer C; Zimmermann D; Hassam S; Odermatt BF; Risti B; Maurer R
Verh Dtsch Ges Pathol; 1992; 76():122-5. PubMed ID: 1283241
[TBL] [Abstract][Full Text] [Related]
38. Intermediate and high-grade gastric non-Hodgkin's lymphoma: a prospective study of non-surgical treatment with primary chemotherapy, with or without radiotherapy.
Haim N; Leviov M; Ben-Arieh Y; Epelbaum R; Freidin N; Reshef R; Ben-Shahar M
Leuk Lymphoma; 1995 Apr; 17(3-4):321-6. PubMed ID: 8580802
[TBL] [Abstract][Full Text] [Related]
39. Successful treatment of enteropathy-associated T cell lymphoma with autologous stem cell transplant.
Rongey C; Micallef I; Smyrk T; Murray J
Dig Dis Sci; 2006 Jun; 51(6):1082-6. PubMed ID: 16865575
[No Abstract] [Full Text] [Related]
40. [A case of enteropathy-associated T-cell lymphoma presenting with recurrent hematochezia].
Yang DH; Myung SJ; Chang HS; Song JW; Yang SK; Lee GH; Jung HY; Hong WS; Kim JH; Min YI; Kim HC; Huh J; Oh HB
Korean J Gastroenterol; 2003 Dec; 42(6):527-32. PubMed ID: 14695710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
